{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein (aS) is linked to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three as point mutations that lead to early onset autosomal dominant Parkinsonism. The normal function of aS is thought to be linked to the ability of the protein to bind to the surface of synaptic vesicles. Upon binding to vesicles, aS undergoes a structural reorganization from a dynamic and disordered ensemble to a conformation consisting of a long extended helix.",
          "judgment": "Yes",
          "reasoning": "The paper links aS to Parkinson's disease and describes that the protein undergoes a structural reorganization to bind to synaptic vesicles, a process disrupted by disease-linked mutations."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Using pulsed dipolar ESR measurements of distances up to 8.7 nm, we show that all three PD-linked as mutants retain the ability to transition from the broken helix to the extended helix conformation. In addition, we find that the ratio of protein to detergent, rather than just the absolute detergent concentration, determines whether the protein adopts the broken or extended helix conformation.",
          "judgment": "Yes",
          "reasoning": "The ESR assay measures protein conformation and its interaction with lipid membranes, reflecting the protein's ability to bind to synaptic vesicles.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Experimental time domain data and respective distance distributions for WT &S and its PD-linked mutants for three spin-labeled variants 24/61 (curve 1 in top panels), 24/72 (curve 2 in top panels), and 24/83 (curve 3 in top panels).",
          "judgment": "Yes",
          "reasoning": "Wild type control is used. Replicates are mentioned in the figure legend.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Not applicable - the paper doesn't use variant controls.",
          "judgment": "No",
          "reasoning": "The study does not use known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "N/A",
          "judgment": "N/A",
          "reasoning": "N/A",
          "next_step_or_outcome": "Proceed to Sub-step 4a"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper provided no statistical tests or calculations.",
          "judgment": "No",
          "reasoning": "There is no statistical analysis in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper uses wild type as the main control. No pathogenic or benign variant controls were used.",
          "judgment": "N/A",
          "reasoning": "Only one control was used, thus the variant count is less than 10.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P variant was demonstrated to retain the ability to transition from broken helix to extended helix, suggesting a functional role in membrane binding, although the study doesn't use variant controls or provide statistical analysis, limiting the strength to PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein (aS) is linked to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three as point mutations that lead to early onset autosomal dominant Parkinsonism. The normal function of aS is thought to be linked to the ability of the protein to bind to the surface of synaptic vesicles. Upon binding to vesicles, aS undergoes a structural reorganization from a dynamic and disordered ensemble to a conformation consisting of a long extended helix.",
          "judgment": "Yes",
          "reasoning": "The paper links aS to Parkinson's disease and describes that the protein undergoes a structural reorganization to bind to synaptic vesicles, a process disrupted by disease-linked mutations."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Using pulsed dipolar ESR measurements of distances up to 8.7 nm, we show that all three PD-linked as mutants retain the ability to transition from the broken helix to the extended helix conformation. In addition, we find that the ratio of protein to detergent, rather than just the absolute detergent concentration, determines whether the protein adopts the broken or extended helix conformation.",
          "judgment": "Yes",
          "reasoning": "The ESR assay measures protein conformation and its interaction with lipid membranes, reflecting the protein's ability to bind to synaptic vesicles.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Experimental time domain data and respective distance distributions for WT &S and its PD-linked mutants for three spin-labeled variants 24/61 (curve 1 in top panels), 24/72 (curve 2 in top panels), and 24/83 (curve 3 in top panels).",
          "judgment": "Yes",
          "reasoning": "Wild type control is used. Replicates are mentioned in the figure legend.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Not applicable - the paper doesn't use variant controls.",
          "judgment": "No",
          "reasoning": "The study does not use known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "N/A",
          "judgment": "N/A",
          "reasoning": "N/A",
          "next_step_or_outcome": "Proceed to Sub-step 4a"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper provided no statistical tests or calculations.",
          "judgment": "No",
          "reasoning": "There is no statistical analysis in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper uses wild type as the main control. No pathogenic or benign variant controls were used.",
          "judgment": "N/A",
          "reasoning": "Only one control was used, thus the variant count is less than 10.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E46K variant was demonstrated to retain the ability to transition from broken helix to extended helix, suggesting a functional role in membrane binding, although the study doesn't use variant controls or provide statistical analysis, limiting the strength to PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein (aS) is linked to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three as point mutations that lead to early onset autosomal dominant Parkinsonism. The normal function of aS is thought to be linked to the ability of the protein to bind to the surface of synaptic vesicles. Upon binding to vesicles, aS undergoes a structural reorganization from a dynamic and disordered ensemble to a conformation consisting of a long extended helix.",
          "judgment": "Yes",
          "reasoning": "The paper links aS to Parkinson's disease and describes that the protein undergoes a structural reorganization to bind to synaptic vesicles, a process disrupted by disease-linked mutations."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Using pulsed dipolar ESR measurements of distances up to 8.7 nm, we show that all three PD-linked as mutants retain the ability to transition from the broken helix to the extended helix conformation. In addition, we find that the ratio of protein to detergent, rather than just the absolute detergent concentration, determines whether the protein adopts the broken or extended helix conformation.",
          "judgment": "Yes",
          "reasoning": "The ESR assay measures protein conformation and its interaction with lipid membranes, reflecting the protein's ability to bind to synaptic vesicles.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Experimental time domain data and respective distance distributions for WT &S and its PD-linked mutants for three spin-labeled variants 24/61 (curve 1 in top panels), 24/72 (curve 2 in top panels), and 24/83 (curve 3 in top panels).",
          "judgment": "Yes",
          "reasoning": "Wild type control is used. Replicates are mentioned in the figure legend.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Not applicable - the paper doesn't use variant controls.",
          "judgment": "No",
          "reasoning": "The study does not use known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "N/A",
          "judgment": "N/A",
          "reasoning": "N/A",
          "next_step_or_outcome": "Proceed to Sub-step 4a"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper provided no statistical tests or calculations.",
          "judgment": "No",
          "reasoning": "There is no statistical analysis in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper uses wild type as the main control. No pathogenic or benign variant controls were used.",
          "judgment": "N/A",
          "reasoning": "Only one control was used, thus the variant count is less than 10.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T variant was demonstrated to retain the ability to transition from broken helix to extended helix, suggesting a functional role in membrane binding, although the study doesn't use variant controls or provide statistical analysis, limiting the strength to PS3_supporting."
    }
  ]
}
